We are live on ! Find out more
FPC

Falcon Point Capital Portfolio holdings

AUM $11.9M
1-Year Est. Return 55.76%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+55.76%
3 Year Est. Return
+118.89%
5 Year Est. Return
+197.9%
10 Year Est. Return
–
AUM
$186M
AUM Growth
+$2.38M
Cap. Flow
-$2.65M
Cap. Flow %
-1.43%
Top 10 Hldgs %
31.53%
Holding
115
New
9
Increased
51
Reduced
28
Closed
10

Top Buys

Rank Stock Value
1
RCM
R1 RCM Inc. Common Stock
RCM
+$4.02M
2
COHR icon
Coherent
COHR
+$2.39M
3
BV icon
BrightView Holdings
BV
+$2.08M
4
ICFI icon
ICF International
ICFI
+$1.82M
5
CONN
Conn's Inc.
CONN
+$1.31M

Top Sells

Rank Stock Value
1
IART icon
Integra LifeSciences
IART
+$3.02M
2
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
+$2.69M
3
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$2.63M
4
TVTX icon
Travere Therapeutics
TVTX
+$1.77M
5
NVTR
Nuvectra Corporation Common Stock
NVTR
+$1.61M

Sector Composition

Rank Sector Weight
1 Industrials 28.92%
2 Technology 18.68%
3 Healthcare 12.11%
4 Consumer Discretionary 11.2%
5 Communication Services 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
76
Mastercard
MA
$477B
$259K 0.14%
978
-23
-2% -$5.76K
APO.PRA
77
DELISTED
Apollo Global Management, Inc. 6.375% Series A Preferred Shares
APO.PRA
$256K 0.14%
10,000
– –
SJB icon
78
ProShares Short High Yield
SJB
$52.1M
$252K 0.14%
11,753
– –
XENE icon
79
Xenon Pharmaceuticals
XENE
$6.32B
$252K 0.14%
+25,608
New +$245K
WPM icon
80
Wheaton Precious Metals
WPM
$50.6B
$236K 0.13%
9,761
-813
-8% -$18K
MSFT icon
81
Microsoft
MSFT
$2.84T
$231K 0.12%
1,721
– –
VRAY
82
DELISTED
ViewRay, Inc.
VRAY
$225K 0.12%
25,556
+7,722
+43% +$62.7K
AMH.PRE
83
DELISTED
American Homes 4 Rent 6.35% Series E Cumulative Redeemable Perpetual Preferred Shares of Beneficial
AMH.PRE
$216K 0.12%
8,000
– –
TRTN
84
DELISTED
Triton International Limited
TRTN
$214K 0.12%
6,540
– –
WTFCM
85
DELISTED
Wintrust Financial Corporation Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series D
WTFCM
$211K 0.11%
7,500
– –
KL
86
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$207K 0.11%
+4,814
New +$167K
HBIO icon
87
Harvard Bioscience
HBIO
$27.1M
$206K 0.11%
10,283
-152
-1% -$4.45K
CSLT
88
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$197K 0.11%
60,984
+626
+1% +$2.16K
AGI icon
89
Alamos Gold
AGI
$12.4B
$159K 0.09%
+26,320
New +$131K
B
90
Barrick Mining
B
$62.2B
$159K 0.09%
10,093
-2,355
-19% -$31.3K
ALDX icon
91
Aldeyra Therapeutics
ALDX
$91.7M
$148K 0.08%
24,701
+280
+1% +$2.11K
SKIS
92
DELISTED
Peak Resorts, Inc.
SKIS
$142K 0.08%
30,000
– –
APEN
93
DELISTED
Apollo Endosurgery, Inc.
APEN
$132K 0.07%
40,749
-24,250
-37% -$86.3K
CSSE
94
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$89K 0.05%
+11,902
New +$105K
IWO icon
95
iShares Russell 2000 Growth ETF
IWO
$14.3B
$66K 0.04%
+327
New +$64.7K
CENTA icon
96
Central Garden & Pet Co Class A
CENTA
$2.41B
– –
-141,173
Closed -$2.63M
DHIL
97
DELISTED
Diamond Hill
DHIL
– –
-2,887
Closed -$404K
DVAX
98
DELISTED
Dynavax Technologies
DVAX
– –
-31,704
Closed -$232K
TVTX icon
99
Travere Therapeutics
TVTX
$5.33B
– –
-78,101
Closed -$1.77M
VKTX icon
100
Viking Therapeutics
VKTX
$4.04B
– –
-118,549
Closed -$1.18M
1 2 3
4
5

Similar funds

GFWEX
G.F.W. Energy X Dallas, Texas $15.3M AUM 35.07% 1-Year Est. Return
SAM
Southpaw Asset Management Stamford, Connecticut $6.92M AUM 3.86% 1-Year Est. Return
VAIA
Virtus Alternative Investment Advisers Hartford, Connecticut $6.71M AUM 36.98% 1-Year Est. Return
HAM
Hammer Asset Management Auburn, California $20.6M AUM 18.22% 1-Year Est. Return
AIDCT
Alfred I duPont Charitable Trust Jacksonville, Florida $2.46M AUM
RC
Resilient Capital London, United Kingdom $1.47M AUM
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
GBA
Global Beta Advisors Philadelphia, Pennsylvania $25K AUM

Falcon Point Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Falcon Point Capital held 115 positions worth $186M, up 1.3% from $184M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Falcon Point Capital's Q2 2019 filing shows 9 new, 51 increased, 28 reduced and 10 closed positions. Its largest new stake was Coherent: 65,530 shares worth $2.4M. The largest sale was Integra LifeSciences, an estimated $3.02M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.

  • Falcon Point Capital's largest Q2 2019 buy was Coherent: 65,530 shares worth $2.4M.
  • Falcon Point Capital added most to R1 RCM Inc. Common Stock in Q2 2019, an estimated $4.02M increase.
  • Falcon Point Capital's biggest Q2 2019 reduction was Integra LifeSciences, cutting an estimated $3.02M.
  • Falcon Point Capital fully exited Benefytt Technologies, Inc. Class A Common Stock in Q2 2019, selling an estimated $2.69M.
  • Falcon Point Capital's ten largest holdings make up 32% of its $186M portfolio in Q2 2019.
  • Falcon Point Capital opened 9 new positions and closed 10 in Q2 2019.
  • Falcon Point Capital's portfolio value rose 1.3% quarter-over-quarter to $186M.

Based on Falcon Point Capital's 13F filing for Q2 2019, filed 15 Jul 2019.